tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Astria Therapeutics downgraded to Neutral from Outperform at Wedbush
PremiumThe FlyAstria Therapeutics downgraded to Neutral from Outperform at Wedbush
16d ago
BioCryst price target raised to $27 from $17 at Citizens JMP
Premium
The Fly
BioCryst price target raised to $27 from $17 at Citizens JMP
16d ago
Astria downgraded to Market Perform from Outperform at Citizens JMP
Premium
The Fly
Astria downgraded to Market Perform from Outperform at Citizens JMP
16d ago
BioCryst price target raised to $15 from $14 at Jefferies
PremiumThe FlyBioCryst price target raised to $15 from $14 at Jefferies
17d ago
Hold Rating on BCRX Amid Strategic Acquisition of Astria Therapeutics and Market Challenges
Premium
Ratings
Hold Rating on BCRX Amid Strategic Acquisition of Astria Therapeutics and Market Challenges
17d ago
Astria Therapeutics downgraded to Hold from Buy at Jefferies
Premium
The Fly
Astria Therapeutics downgraded to Hold from Buy at Jefferies
17d ago
Astria Therapeutics Announces Merger with BioCryst
PremiumCompany AnnouncementsAstria Therapeutics Announces Merger with BioCryst
17d ago
BioCryst to acquire Astria Therapeutics for $13.00 per share
Premium
The Fly
BioCryst to acquire Astria Therapeutics for $13.00 per share
17d ago
BioCryst to acquire Astria Therapeutics for $13.00 per share
Premium
The Fly
BioCryst to acquire Astria Therapeutics for $13.00 per share
17d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100